Pacific Biosciences Of California Inc (PACB) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Pacific Biosciences Of California Inc   (NASDAQ: PACB)


Pacific Biosciences Of California Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Pacific Biosciences Of California Inc's ROI in the second quarter of 2026?
Pacific Biosciences Of California Inc recorded a cumulative net loss of $-131 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -18.43%.

Within the Healthcare sector 297 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3215 to 3275.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -31.2 % -39 % -46.35 % -42.43 % -35.18 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 683 717 711 740 766
Return On Investment (TTM) -18.43 % -17.53 % -72.58 % -57.66 % -50.81 %
PACB's Overall Ranking # 3275 # 3215 # 3447 # 3531 # 3055
Seq. Investment Change TTM -2.82 % -2.56 % -13.82 % -15.69 % -13.83 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -131 -129 -546 -504 -526

PACB Company Profile >> Back to PACB Roi Comparisons >> See Annual PACB Return On Investment



Return On Investment PACB's Ranking
Within: No.
Industry # 13
Sector # 298
Overall # 3275

Return On Investment Statistics
High Average Low
16.09 %
-47.69 %
-91.8 %
(Dec 31 2020)   (Sep 30 2019)



  News about Pacific Biosciences Of California Inc Return on Investment ROI

Advancing Genomic Horizons PacBios Innovations in Long-Read Sequencing

November 7, 2024

In a significant stride towards democratizing genomic research, Pacific Biosciences (PacBio) has launched the Vega System, a new benchtop sequencing platform priced at $169,000. This development aims to make highly accurate long-read sequencing accessible to a wider array of laboratories. The Vega System utilizes HiFi sequencing technology, known for its precision, which is crucial in various fields of biological research, including oncology, reproductive health, and genetic disease studies.The introduction of the Vega System reflects PacBio s commitment to making advanced sequencing technologies more available to researchers and healthcare providers. Long-read sequencing, which allows for more extensive genomic analyses than short-read techniques, has been associated with improved accuracy in the identification of genetic variations. The affordability of the Vega system could lower barriers for many laboratories, fostering innovation and research capabilities across diverse scientific domains.





Financial Statements
Pacific Biosciences Of California Inc's II. Quarter Investments $ 683 Millions PACB's Balance sheet
Pacific Biosciences Of California Inc's II. Quarter Income $ -45 Millions Quarterly PACB's Income Statement
PACB's Income by Division See PACB's Income by Division


PACB Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 711 1,194 1,651 1,504 1,935
Y / Y Investment Growth -40.44 % -27.67 % 9.79 % -22.3 % 415.41 %
Net Income in Millions -546 -310 -307 -314 -181
Y / Y Net Income Growth - - - - -
Annual Return On Investment -76.82 % -25.95 % -18.58 % -20.9 % -9.36 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PACB's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PACB's Competitors
Subscribers only: Roi for Pacific Biosciences Of California Inc's Suppliers
Subscribers only: Return On Investment for PACB's Customers

Other Ratios
PACB's Roa PACB's Inventory Turnover Ratio PACB's Growth Rates PACB's Dividend Statistics
PACB's Profitability Ratios PACB's Asset Turnover Ratio PACB's Dividend Growth
PACB's Roe PACB's Valuation Ratios PACB's Financial Strength Ratios PACB's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-12T06:13:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.